0001209191-11-061835.txt : 20111216
0001209191-11-061835.hdr.sgml : 20111216
20111216172226
ACCESSION NUMBER: 0001209191-11-061835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111214
FILED AS OF DATE: 20111216
DATE AS OF CHANGE: 20111216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH GROWTH N V
CENTRAL INDEX KEY: 0001259869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53173
FILM NUMBER: 111267373
MAIL ADDRESS:
STREET 1: DE RUYTERKADE 62 WILLEMSTAD
CITY: CURACO
STATE: P8
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Radius Health, Inc.
CENTRAL INDEX KEY: 0001428522
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 800145732
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 425 9225
MAIL ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MPM ACQUISITION CORP
DATE OF NAME CHANGE: 20080228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53173
FILM NUMBER: 111267372
BUSINESS ADDRESS:
STREET 1: VODERGASSE 3
STREET 2: SWITZERLAND
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: CH-8300
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: VODERGASSE 3
STREET 2: SWITZERLAND
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: CH-8300
4
1
c26022_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0304
4
2011-12-14
0001428522
Radius Health, Inc.
NONE
0001259869
BIOTECH GROWTH N V
SNIPWEG 26
CURACAO
00000
0
0
1
0
0000924223
BB BIOTECH AG
VORDERGASSE 3
SCHAFFHAUSEN
V8
8200
SWITZERLAND
0
0
1
0
Series A-1
Convertible
Preferred Stock
2011-12-14
4
P
0
40940
A
Common Stock
409400
122820
D
Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech and Biotech Growth N.V.
Each share of Series A-1 Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion ratio of 10 shares of Common Stock for every 1 share of Preferred Stock.
/s/ Pascal Schmucki, Signatory Authority for Biotech Growth N.V. and BB Biotech AG
2011-12-16